Sabra Health Care REIT, Inc. SBRA
Set alert
20.09 USD +0.37 +1.88%
As of Nov 3, 11:27 AM ET
19.57 Day range 20.29
17.54 52-week range 22.77
- YTD
- +6.07%
- 1 year
- +12.30%
- Open
- 19.57
- Prev close
- 19.72
- Mkt cap
- 5.13B
- Vol
- 1.14M
- Avg vol
- 2.38M
- EPS
- 0.25
- P/E
- 80.38
- Div yield
- 6.12%
More statistics
- Low
- 19.57
- High
- 20.29
- Forward P/E
- 24.35
- Beta
- 0.64
- Short ratio
- 6.95
- Inst. own
- 105.26%
- Dividend
- 1.20
- Ex-div date
- Aug 13, 2026
- Earnings
- Feb 11, 2027
- 50-d avg
- 19.87
- 200-d avg
- 19.97
- 1y target
- 22.36
Analyst view
Consensus: buy
Buy
Price target (mean) 22.36 +11.3% upside
Now 20.09
- Target (low)
- 19.00
- Target (mean)
- 22.36
- Target (high)
- 25.00
Ratings (0m) 16 6 buy · 10 hold · 0 sell
- Strong buy1
- Buy5
- Hold10
- Sell0
- Strong sell0
Recommendation trend
- This month 16
- 1 month ago 16
- 2 months ago 16
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.165 | 0.16 – 0.17 | 0.1664 | -0.8% | 236.37M | +24.4% | 2 |
| Next quarter | 0.17667 | 0.17 – 0.18 | 0.1592 | +11.0% | 243.29M | +14.8% | 3 |
| Current year | 0.40466 | 0.38271 – 0.44 | 0.64 | -36.8% | 926.51M | +19.6% | 8 |
| Next year | 0.81 | 0.77 – 0.85 | 0.00 | 0.0% | 1.02B | +10.5% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 13, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 13, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 31, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 31, 2026 | Baird | Maintained | Neutral | Neutral |
| Aug 6, 2026 | Raymond James | Upgrade | Underperform | Market Perform |
| Jul 22, 2026 | Baird | Maintained | Neutral | Neutral |
| Jul 22, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 22, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jul 8, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 8, 2026 | Truist Securities | Upgrade | Hold | Buy |
| Jul 7, 2026 | Barclays | Initiated | Equal-Weight | Equal-Weight |
| Jun 23, 2026 | Citigroup | Downgrade | Buy | Neutral |
| Jun 18, 2026 | Scotiabank | Maintained | Sector Perform | Sector Perform |
| Jun 1, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 21, 2026 | Scotiabank | Maintained | Sector Perform | Sector Perform |
| May 13, 2026 | UBS | Maintained | Neutral | Neutral |
| May 11, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Mar 26, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 13, 2026 | Truist Securities | Maintained | Hold | Hold |
| Mar 2, 2026 | Scotiabank | Maintained | Sector Perform | Sector Perform |
| Feb 19, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 18, 2026 | Citigroup | Maintained | Buy | Buy |
| Feb 18, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Feb 17, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Jan 20, 2026 | Truist Securities | Maintained | Hold | Hold |
| Nov 25, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 18, 2025 | UBS | Initiated | — | Neutral |
| Oct 21, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 1, 2025 | Cantor Fitzgerald | Initiated | — | Neutral |